Detection of Anabolic Androgenic Steroids and Steroid Esters—Comparing Dried Blood Spots Collection Devices and Urine Samples
Drug Testing and Analysis · 2025
DOI: 10.1002/dta.3950 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Tina Suominen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Helsinki Doping Control Laboratory, Finnish Institute for Health and Welfare, Helsinki, Finland. Hauptthemen laut MEDLINE: Substance Abuse Detection, Dried Blood Spot Testing, Anabolic Agents, Androgens. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Dried blood spots (DBS) have emerged as a promising complement, and in some settings, an alternative, to urine for anabolic androgenic steroid (AAS) testing, offering advantages such as minimal invasiveness, simplified storage, and transportation. This study evaluated two DBS collection devices—cellulose‐based Capitainer‐B50 and polymer‐based Tasso‐M20—and compared results with traditional urine analysis. Ten self‐reported AAS users were recruited and provided matched urine and DBS samples. High agreement between the two DBS devices was observed, although Capitainer‐B50 showed a slightly greater detection rate, likely due to a higher sample volume (50 μL vs. 17.5 μL) improved analyte recovery, and lower background noise. Notably, DBS enabled detection of testosterone use in all 10 participants, while urine testing missed two cases with naturally low urinary testosterone/epitestosterone (T/E) ratios (most likely UGT2B17 del/del carriers). Moreover, the differentiation between prescribed and illicit use of testosterone esters was also possible in DBS, but not in urine testing, while nandrolone detection in DBS was limited at low concentrations. The findings support DBS as a sensitive and practical tool for AAS detection and provide critical advantages in detecting doping with testosterone esters in individuals with prescribed testosterone therapy and in UGT2B17 deletion carriers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Helsinki Doping Control Laboratory, Finnish Institute for Health and Welfare, Helsinki, Finland.
- Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
- Doping Control Laboratory, MU Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden.
- Department of Medicine, Karolinska Institute, Stockholm, Sweden.
ORCID-Profile: Jenny Schulze, Lena Ekström
Zitieren
APA
Suominen, T., von Walden, J., Harju, L., Pohanka, A., Schulze, J., Lehtihet, M., & Ekström, L. (2025). Detection of Anabolic Androgenic Steroids and Steroid Esters—Comparing Dried Blood Spots Collection Devices and Urine Samples. Drug Testing and Analysis. https://doi.org/10.1002/dta.3950
Vancouver
Suominen T, von Walden J, Harju L, Pohanka A, Schulze J, Lehtihet M, et al. Detection of Anabolic Androgenic Steroids and Steroid Esters—Comparing Dried Blood Spots Collection Devices and Urine Samples. Drug Testing and Analysis. 2025. doi:10.1002/dta.3950
BibTeX
@article{Suominen2025,
author = {Suominen, Tina and von Walden, Jeanette and Harju, Laura and Pohanka, Anton and Schulze, Jenny and Lehtihet, Mikael and Ekström, Lena},
title = {Detection of Anabolic Androgenic Steroids and Steroid Esters—Comparing Dried Blood Spots Collection Devices and Urine Samples},
journal = {Drug Testing and Analysis},
year = {2025},
doi = {10.1002/dta.3950}
}
EUVIMED